Literature DB >> 15238100

UVA-1 as a treatment for scleredema.

Jennifer J Janiga1, Donna H Ward, Henry W Lim.   

Abstract

Scleredema is a rare disease that is difficult to treat. Many therapies have been tried with varied and somewhat inconsistent results. Here we report two cases of scleredema successfully treated with low-dose UVA-1.

Entities:  

Mesh：

Year:  2004        PMID： 15238100     DOI： 10.1111/j.1600-0781.2004.00106.x

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN： 0905-4383            Impact factor:   3.135


  5 in total

1.  [Scleredema diabeticorum: successful treatment with UVA-1 phototherapy].

Authors:  C Kochs; A Bockmann; S Hanneken; N J Neumann
Journal:  Hautarzt       Date:  2011-04       Impact factor: 0.751

Review 2.  [Scleredema adultorum : Clinical presentation, diagnostic workup, differential diagnosis, treatment option].

Authors:  A Kreuter
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

3.  Scleredema diabeticorum in a patient with type 2 diabetes mellitus.

Authors:  C Martín; L Requena; K Manrique; F D Manzarbeitia; A Rovira
Journal:  Case Rep Endocrinol       Date:  2011-07-31

4.  Scleredema Diabeticorum with Superimposed Cellulitis and Abscess Formation.

Authors:  Binav Shrestha; Eliza Sharma; Osama Mukhtar; Jaspreet Kaler; Shivani Thapa; Mazin Khalid
Journal:  Case Rep Endocrinol       Date:  2018-04-16

Review 5.  Ultraviolet A1 Phototherapy for Fibrosing Conditions.

Authors:  Thilo Gambichler; Lutz Schmitz
Journal:  Front Med (Lausanne)       Date:  2018-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.